Withdrawal Management and Methadone Initiation in the Hospital Setting
As of 2024, hospital providers reported changes in the characteristics and severity of withdrawal symptoms attributed to the dynamic illicit drug supply. This has increased the urgency on identifying protocols that effectively manage pain and withdrawal in a hospital setting. Methadone is an evidence-based medication for treating withdrawal but remains underutilized in the hospital setting for several reasons, such as concerns about discharge strategy and misconceptions about titration, effect, and regulation.
Faculty will review the initiation and titration of methadone in hospital settings, as well as outline changes in withdrawal symptoms observed by local practitioners. Presentations will be followed by a panel discussion that will illustrate strategies for implementing best practices for treating withdrawal in the emergency department and inpatient settings, as well as how to leverage recent policy changes to improve transitioning patients initiated on methadone in the hospital to opioid treatment programs in their communities.
Registration: https://zoom.us/webinar/register/WN_z4iVL2VyQ6CghZmuvOgUEw
Faculty:
Ashish Thakrar, MD, MS, FASAM, Assistant Professor of Medicine, Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine
Kory S. London, MD, FACEP, Director of Clinical Operations - Jefferson Methodist Hospital ED, Stroke Medical Director – Jefferson Methodist Hospital, Associate Director of Quality and Safety, Associate Professor of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University
Panelists:
Rebecca Jaffe, MD, Associate Professor of Medicine, Division Director, Hospital Medicine, Vice Chair for Inpatient Services, Dept of Medicine
Sam Huo, MD, MPH, MS, Assistant Professor of Clinical Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Director, Addiction Consult Team, Penn Presbyterian Medical Center, Center for Addiction Medicine and Policy
Nikole Papas, Executive Director, Merakey Parkside Recovery
Moderated by: Jeanmarie Perrone, MD FACMT, Professor, Emergency Medicine, Director, Medical Toxicology and Addiction Medicine Initiatives, Department of Emergency Medicine, Center for Addiction Medicine and Policy, Perelman School of Medicine at the University of Pennsylvania
CME, Nursing, Social Work, and Pharmacy Credits Offered
Target Audience: Healthcare professionals, including physicians, advanced practitioners, nurses, and pharmacists, who treat patients with
substance use disorders.
Learning Objectives: After attending this program, participants will be able to:
- Describe the federal regulatory framework for when methadone can be administered and dispensed in the hospital setting.
- Discuss how drug contamination has altered the symptoms and conditions treated in hospital settings due to combined use of synthetic opioids as well as other illicit substances.
FEE: There is no fee for this program.
Registration: https://zoom.us/webinar/register/WN_z4iVL2VyQ6CghZmuvOgUEw